Form D — Converge Bio Inc.
0002131104-26-000001 · filed 2026-04-28
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $25,000,000
- Total sold
- $25,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Converge Bio Inc.
- CIK
- 2131104
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 2093 PHILADELPHIA PIKE #1664
CLAYMONT, DE 19703 - Phone
- 6173518116
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Dov Gertz · Executive OfficerClaymont, DE Find on LinkedIn ↗
-
Oded Kalev · Executive OfficerClaymont, DE Find on LinkedIn ↗
-
Shahar Tzafrir · DirectorClaymont, DE Find on LinkedIn ↗
-
Andrew Hedin · DirectorClaymont, DE Find on LinkedIn ↗
-
Iddo Weiner · Executive OfficerClaymont, DE Find on LinkedIn ↗
View original on SEC EDGAR.